Log in to save to my catalogue

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repur...

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repur...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_36674724

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repurposing Approaches towards the Discovery of Effective BH 4 Therapeutics

About this item

Full title

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repurposing Approaches towards the Discovery of Effective BH 4 Therapeutics

Author / Creator

Publisher

Switzerland

Journal title

International journal of molecular sciences, 2023-01, Vol.24 (2)

Language

English

Formats

Publication information

Publisher

Switzerland

More information

Scope and Contents

Contents

The GTP cyclohydrolase 1 enzyme (GTPCH1) is the rate-limiting enzyme of the tetrahydrobiopterin (BH
) biosynthetic pathway. Physiologically, BH
plays a crucial role as an essential cofactor for the production of catecholamine neurotransmitters, including epinephrine, norepinephrine and dopamine, as well as the gaseous signaling molecule, nitr...

Alternative Titles

Full title

In Silico Investigation of the Human GTP Cyclohydrolase 1 Enzyme Reveals the Potential of Drug Repurposing Approaches towards the Discovery of Effective BH 4 Therapeutics

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_36674724

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_36674724

Other Identifiers

E-ISSN

1422-0067

DOI

10.3390/ijms24021210

How to access this item